News & Events

Naobios was proud to participate in the World Vaccine Congress Europe 2025 in Amsterdam, connecting with the global vaccine community and showcasing our expertise in viral product development, GMP manufacturing, and process optimization.

Our team, represented by Gaëtan Blaize, Ph.D., Business Development Director, and Ysaline Roland, Head of Bioprocess Development, welcomed visitors at our booth, sharing how Naobios supports programs in viral banking, QC testing, oncolytic viruses, and Human Viral Challenge Agents (HVCA).

During the event, Ysaline took part in the roundtable “Making Vaccines Real: Aligning Science, Capital, and Supply Chains for Global Impact”, discussing how science, investment, and manufacturing can come together to accelerate vaccine development.

She also gave a presentation on HVCA manufacturing, highlighting this safe GMP solution that provides critical insights into human immune responses, enabling faster and safer vaccine development.

If you couldn’t attend the event, don’t miss the opportunity to learn more about our expertise by watching our interview with Gaëtan Blaize, where he explains why Naobios is a trusted CDMO partner for viral product development, from process design to GMP manufacturing.

Naobios continues to bring expertise, flexibility, and compliance to support biotech, CRO, and pharma companies in advancing their viral vaccine programs.